Autres langues GlaxoSmithKline plc LIQUIDNET SYSTEMS

Actions

GSK

GB0009252882

Produits pharmaceutiques

Temps Différé LIQUIDNET SYSTEMS Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-0,40 %	-

24/07	Les bourses européennes clôturent en hausse vendredi ; le secteur privé de la zone euro progresse en juillet	MT
24/07	GSK : JP Morgan reste pessimiste	ZD

Autres langues

24/07	European Stocks Close Higher Friday; Eurozone Private Sector Expands in July
24/07	WOCHENVORSCHAU/27. Juli bis 2. August 2026 (31. KW)
24/07	GSK Canada Wins Approval for Prefilled Shingrix Syringe
24/07	GSK Wins European Medicines Agency's Positive Opinion on Lynavoy for Liver Disease-Related Itch
24/07	UBS cuts Standard Chartered; Shore ups HSBC
23/07	Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.
23/07	GSK plc - Jideytro approved in the US for previously treated ROS1-positive non-small cell lung cancer
23/07	Afternoon Meeting: Un barril de Brent a 100 USD sacudiría los mercados
23/07	100 US-Dollar für Brent verändern die Spielregeln
23/07	Brent at $100 Changes the Equation
23/07	Oil Tops $98 a Barrel, Tech Earnings Worry Markets
23/07	UK Stocks-Factors to watch on July 23
23/07	Morning Meeting: Los bancos centrales, atrapados por la inflación
23/07	Central bankers caught out by inflation
23/07	UK stocks - factors to watch on July 23
23/07	GSK Wins First Approval in Lung Cancer as US FDA OKs Jideytro
22/07	GSK Plc Receives FDA Approval For Jideytro In US For ROS1-Positive Non-Small Cell Lung Cancer
22/07	GSK hails first lung cancer medicine approval as US FDA backs Jideytro
22/07	GSK Gets FDA Approval for Jideytro in Previously Treated ROS1-Positive Lung Cancer
22/07	GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers
22/07	GSK : Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer
22/07	GSK enters lung cancer drug market with early FDA nod for Jideytro
21/07	Novartis backs full year forecast after $6 billion profit beat helped by one-offs
20/07	Gsk plc Receives European Medicines Agency Acceptance for Submission to Update Bexsero Label for 1-Dose Meningitis B Booster in Individuals Aged 10 Years and Older
20/07	GSK secures European review for meningitis vaccine booster